Dynavax Technologies | Driftsomkostninger

Operating Expenses Lave om Dato
AbbVie USD 11.11B 540M 2023-12
Adma Biologics USD 85.84M 27.26M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Dynavax Technologies USD 64.09M 311K 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Dynavax Technologies Driftsomkostninger - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.